Cargando…

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection

Purpose: There is still lacking of highly sensitive and specific biomarkers for the prediction of hepatocellular carcinoma (HCC) early recurrence, which has hindered further improvement of the clinical outcomes. We aim to find highly sensitive and specific biomarkers for the prediction of HCC recurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hongzhi, Chen, Hui, Wu, Xiaomo, Sun, Ying, Wang, Yingchao, Zeng, Yongyi, Chen, Geng, Liu, Xiaolong, Xing, Xiaohua, Zhao, Bixing, Liu, Jingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497822/ https://www.ncbi.nlm.nih.gov/pubmed/31114342 http://dx.doi.org/10.2147/CMAR.S190561

Ejemplares similares

Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection
por: Huang, Xinhui, et al.
Publicado: (2014)

Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials
por: Liu, Hongzhi, et al.
Publicado: (2018)

Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma
por: Xing, Xiaohua, et al.
Publicado: (2021)

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study
por: Wu, Yijun, et al.
Publicado: (2022)

Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesions
por: Xing, Xiaohua, et al.
Publicado: (2015)

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
por: Zhong, Yue, et al.
Publicado: (2021)

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection
por: Huang, Yao, et al.
Publicado: (2021)

Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model
por: Liao, Naishun, et al.
Publicado: (2020)

Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion
por: Liao, Naishun, et al.
Publicado: (2019)

Prognostic significance of three‐tiered pathological classification for microvascular invasion in patients with combined hepatocellular‐cholangiocarcinoma following hepatic resection
por: Wu, Yijun, et al.
Publicado: (2022)

Role of exosomes in hepatocellular carcinoma cell mobility alteration
por: Wang, Sen, et al.
Publicado: (2017)

Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review
por: Lin, Nanping, et al.
Publicado: (2020)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
por: Liao, Naishun, et al.
Publicado: (2017)

Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
por: You, Song, et al.
Publicado: (2022)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma
por: Lin, Kongying, et al.
Publicado: (2021)

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
por: Cai, Zhixiong, et al.
Publicado: (2021)

The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis
por: Wang, Lei, et al.
Publicado: (2017)

4E-BP1(Thr46) Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC
por: Lin, Xincong, et al.
Publicado: (2020)

Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns
por: Li, Zhenli, et al.
Publicado: (2021)

MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
por: Wang, Yingchao, et al.
Publicado: (2019)

Prognostic Value of MicroRNA-497 in Various Cancers: A Systematic Review and Meta-Analysis
por: Liu, Zhiqiang, et al.
Publicado: (2019)

An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
por: Zhao, Bixing, et al.
Publicado: (2019)

Dataset for quantitative phospho-proteomics analysis of a serial hepatoma cell lines with increasing invasion and metastasis potential
por: Xing, Xiaohua, et al.
Publicado: (2019)

HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis
por: Zhao, Bixing, et al.
Publicado: (2020)

Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming
por: Zhang, Fangrong, et al.
Publicado: (2021)

Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection
por: Zeng, Jianxing, et al.
Publicado: (2020)

Circular RNA profiling identifies circADAMTS13 as a miR‐484 sponge which suppresses cell proliferation in hepatocellular carcinoma
por: Qiu, Liman, et al.
Publicado: (2019)

Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China
por: Ke, Qiao, et al.
Publicado: (2023)

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021)

A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma
por: Lin, Nanping, et al.
Publicado: (2022)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection
por: Feng, Jiliang, et al.
Publicado: (2017)

Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization
por: Ke, Qiao, et al.
Publicado: (2021)

Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
por: Zeng, Yongyi, et al.
Publicado: (2020)

Universal two‐dimensional labelled probe‐mediated melting curve analysis based on multiplex PCR for rapid typing of Plasmodium in a single closed tube
por: Xu, Haipo, et al.
Publicado: (2023)

Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study
por: Zeng, Jianxing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mqulr8qek118clokka2dadcba